Improve Research Reproducibility
A Bio-protocol resource
Home
Protocols
Biochemistry
Biophysics
Cancer Biology
Cell Biology
Developmental Biology
Immunology
Microbiology
Molecular Biology
Neuroscience
Plant Science
Stem Cell
Systems Biology
Articles and Issues
Current Issue
All Issues
Articles In Press
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Article Processing Charges
About
About Us
Aims ＆ Scope
Advisors
Editors
Reviewers
Leadership and Management
Open Access Policy
Content Availability and Indexing
Journal Partners
Contact Us
Advanced Search
EN
EN - English
CN - 中文
CN
Log in / Sign up
Bio Page
Edit Profile
Home
Protocols
Biochemistry
Biophysics
Cancer Biology
Cell Biology
Developmental Biology
Immunology
Microbiology
Molecular Biology
Neuroscience
Plant Science
Stem Cell
Systems Biology
Articles and Issues
Current Issue
All Issues
Articles In Press
For Authors
Submission Procedure
Preparation Guidelines
Submit Manuscript
Editorial Process
Editorial Criteria
Publishing Ethics
Competing Interests
Article Processing Charges
About
About Us
Aims & Scope
Advisors
Editors
Reviewers
Leadership and Management
Open Access Policy
Content Availability and Indexing
Journal Partners
Contact Us
Overview
Authored
(1)
Q&A
(2)
WW
Wesley A. Wierson
Founder and CEO, LifEngine Animal Health Laboratories Incorporated
Research fields
Cell Biology, Molecular Biology, CAR-T, CRISPR, Gene editing
Find out more
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.